Table 1.

Clinical and laboratory characteristics of SLE patients

Patient number	Glomerulonephritis class	Proteinuria (g/day)	SLEDAI score	Basal PAF (pg/106 cells)	IL-10-stimulated PAF (pg/106 cells)
1	III	2·9	14	500	750
2	III + V	3	15	450	780
3	NB	0·2	12	50	120
4	IV	2·4	4	35	45
5	NB	0·2	8	30	110
6	V	1·7	16	65	180
7	IV	0·5	4	85	90
8	NB	0·2	3	45	45
9	III	0·61	2	25	25
10	III + V	0·4	2	58	58
11	NB	0·18	4	48	65
12	IV + V	0·3	4	20	20
13	III	0·3	2	20	35
14	III + V	0·08	6	45	50
15	NB	0·3	4	50	110
16	III + V	0·3	2	88	86
17	V	2·3	6	35	44
18	III	1·4	4	28	42
19	III	2·1	22	56	120
20	III	1·7	4	46	45
21	NB	3	12	ND	225
22	NB	1	24	56	104
23	V	3	18	150	200
24	III + V	1·3	14	60	100
25	V	3	10	270	320
26	III + V	1·7	12	60	65
27	IV	7·3	22	90	365

Disease activity was indicated using the SLEDAI score. PAF production by monocytes was valuated in basal conditions and after IL‐10 (20 ng/ml) stimulation, as described in PATIENTS and METHODS. NB, Not biopsy.